"About Delaware Arthritis Delaware Arthritis is a rheumatology practice located in Lewes, Delaware. Under the medical direction of board-certified rheumatologist Jose A. Pando, MD, Delaware Arthritis is dedicated to providing comprehensive and compassionate care that focuses on a patient’s whole health, not just the symptoms or disease. Our rheumatology practice specializes in many diseases that affect the musculoskeletal system, including many types of arthritis such as osteoarthitis and autoimmune disorders (like psoriatic arthritis and rheumatoid arthritis), as well as chronic health conditions such as fibromyalgia and osteoporosis."

During the past decade, Delaware Arthritis conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 12 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Delaware Arthritis" #1 sponsor was "Pfizer" with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Crescendo Bioscience" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delaware Arthritis" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator, "Laboratory Corporation of America" with 1 trials as a collaborator, "OCT Clinical Trials" with 1 trials as a collaborator, "Oregon Health and Science University" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Delaware Arthritis" are "Rheumatoid Arthritis" (10 trials), "Arthritis, Rheumatoid" (2 trials), "Osteoarthritis" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Delaware Arthritis" in a lesser frequency.

Most popular intervention types in "Delaware Arthritis" are "Drug" (12 trials), "Biological" (4 trials), "Other" (3 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (3 trials), "Placebo" (3 trials), "Methotrexate" (2 trials), "Active stimulation" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delaware Arthritis" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Delaware Arthritis". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Delaware Arthritis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Delaware Arthritis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".